Seattle Genetics (SGEN) Misses Q2 EPS by 11c, Revenues Beat; Offers FY19 Revenue Guidance
Tweet Send to a Friend
Seattle Genetics (NASDAQ: SGEN) reported Q2 EPS of ($0.49), $0.11 worse than the analyst estimate of ($0.38). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
